Coronary disease & ACS

First-in-Human Experience With a Novel Monorail Microcatheter for Instantaneous Coronary Pressure and Flow Velocity Measurements

JACC AdvPublished First-in-human, prospective, single-arm study

Authors' conclusion

In this first-in-human experience, the PyCath microcatheter enabled safe and reproducible measurements of intracoronary pressure and flow velocity with excellent reproducibility.

Study context

Population
Patients with a clinical indication for coronary physiology assessment
Participants
17 patients
Outcome
Procedural safety (device-related major adverse cardiac events) and device performance (successful acquisition of pressure and velocity signals)
Methodological detailsindependent core laboratory analysis
  • Independent core laboratory analysis

Main finding

As reported in the abstract

Intracoronary pressure measurements feasible
100%
Velocity measurements feasible
88%
Device-related major adverse cardiac events
There were no device-related major adverse cardiac events

Observational data: associations, not effects.

Further findings

Time required to obtain both measurements

Mean time
70.6 ± 23.6 seconds

Physiology indices

Mean fractional flow reserve
0.84 ± 0.12
Mean coronary flow velocity reserve
2.28 ± 0.79
Mean hyperemic microvascular resistance
1.46 ± 0.77

Test-retest reproducibility (intraclass correlation coefficients)

Fractional flow reserve ICC
0.979 (0.934-0.993)
Coronary flow velocity reserve ICC
0.798 (0.477-0.933)
Hyperemic microvascular resistance ICC
0.759 (0.397-0.919)
  • Good-to-excellent

Original publication

First-in-Human Experience With a Novel Monorail Microcatheter for Instantaneous Coronary Pressure and Flow Velocity Measurements. JACC Adv. Published 11 November 2026. doi:10.1016/j.jacadv.2026.103445

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.